GlassScriptPhysician profile
Soe Naing
NPI 1467650341
$18,570.24
in general payments reported to CMS, 2019-2025
50 companies · $7,730 in 2025
The $7,730 reported for 2025 was more than what 89% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $270 · 2021: $930 · 2022: $2,689 · 2023: $3,671 · 2024: $3,162 · 2025: $7,730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $3,200 · Travel and Lodging: $375 · Education: $0.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,988.07 |
| Consulting Fee | $3,200.00 |
| Travel and Lodging | $374.52 |
| Education | $0.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $4,077.02 | 2024-2025 | |
| Lilly USA, LLC | $1,834.34 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $1,498.12 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $1,201.78 | 2020-2025 | Freestyle Libre 3 |
| Amgen INC. | $1,014.63 | 2022-2025 | Tepezza, Evenity, Repatha |
| Tandem Diabetes Care, INC. | $675.33 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Sanofi-Aventis U.S. LLC | $598.84 | 2020-2025 | |
| Dexcom, INC. | $563.02 | 2020-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $529.37 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Corcept Therapeutics | $526.04 | 2020-2025 | Korlym |
| Radius Health, INC. | $423.59 | 2022-2025 | Tymlos |
| Recordati_rare_diseases_inc. | $422.85 | 2022-2025 | Isturisa, Signifor Lar |
| Insulet Corporation | $422.22 | 2020-2025 | Omnipod |
| Alexion Pharmaceuticals, INC. | $401.75 | 2022-2025 | Strensiq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $380.72 | 2022-2025 | Jardiance, Synjardy |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $354.75 | 2021-2025 | Afrezza |
| Antares Pharma, INC. | $342.15 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Abbvie INC. | $322.26 | 2022-2025 | |
| Ultragenyx Pharmaceutical INC. | $286.22 | 2021-2025 | Crysvita |
| Xeris Pharmaceuticals, INC. | $278.16 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $255.63 | 2022-2025 | |
| Horizon Therapeutics Plc | $228.35 | 2021-2023 | Tepezza |
| Ascendis Pharma Endocrinology INC | $205.21 | 2023-2025 | Yorvipath |
| Kvk-Tech, INC. | $185.65 | 2024-2025 | |
| Halozyme INC | $156.15 | 2023 | |
| Verity Pharmaceuticals INC. | $143.34 | 2024-2025 | Tlando |
| Kyowa Kirin, INC. | $129.40 | 2023-2025 | Crysvita |
| Astrazeneca Pharmaceuticals LP | $115.38 | 2022-2024 | Farxiga |
| Pfizer INC. | $111.18 | 2021-2025 | |
| Madrigal Pharmaceuticals | $98.33 | 2025 | Rezdiffra |
| Nevro Corp. | $79.41 | 2022-2023 | Senza |
| Amryt Pharma Holdings LTD | $76.46 | 2022-2023 | Mycapssa |
| Ascensia Diabetes Care US INC. | $73.11 | 2024 | |
| Rgh Enterprises LLC | $64.01 | 2025 | |
| Beta Bionics, INC. | $52.49 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Ibsa Pharma INC. | $46.18 | 2021-2023 | Tirosint, Licart |
| Medtronic Minimed, INC. | $44.82 | 2020 | |
| Cequr Corporation | $44.74 | 2023-2024 | Cequr Simplicity |
| Sequel Med Tech, LLC | $36.13 | 2025 | Twiist |
| Ionis Pharmaceuticals, INC. | $36.04 | 2025 | Tryngolza |
| Esperion Therapeutics, INC. | $33.74 | 2021-2023 | Nexletol |
| Currax Pharmaceuticals LLC | $30.70 | 2025 | Contrave |
| Bigfoot Biomedical INC | $25.56 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $24.97 | 2021 | |
| Acella Pharmaceuticals, LLC | $24.97 | 2024 | NP Thyroid 60 |
| Alvogen INC | $24.78 | 2025 | Teriparatide |
| Eusa Pharma (US) LLC | $22.43 | 2022 | |
| Averitas Pharma INC. | $21.58 | 2024 | Qutenza |
| Becton, Dickinson and Company | $14.80 | 2022 | |
| Eisai INC. | $11.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soe Naing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.